Skip to main content

Advertisement

Log in

Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

To propose an ultrasound-based parameter for the diagnosis of muscle mass loss (MML) in cirrhosis.

Methods

This is an IRB-approved cross-sectional study (October 2013 to January 2017) with written informed consent including 357 subjects—234 cirrhosis and 123 controls. MML was diagnosed using the skeletal muscle index at the L3 level (L3-SMI) on computed tomography (CT). Transcutaneous ultrasound was used to demonstrate a cross section of the right iliopsoas muscle, and the iliopsoas muscle index (IP index) was defined by the iliopsoas muscle area/height2 (mm2/m2). Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic ability of IP index for MML.

Results

The iliopsoas muscle was detected in all subjects. The IP index was lower in cirrhosis than in controls: males (211.2 ± 73.8 vs. 295.5 ± 139.4, P < 0.0001) and females (200.2 ± 72.5 vs. 284.4 ± 112.4, P < 0.0001). L3-SMI and IP index showed correlations in males (r = 0.699, P < 0.0001) and in females (r = 0.707, P < 0.0001). Independent factors for MML by multivariate analysis were body mass index and IP index in both males and females. Sensitivity, specificity, and area under the ROC curve by IP index to detect MML were 79.5%, 73.1%, and 0.835, respectively, with the best cut-off value of 189.2 for males, and 84.6%, 78.8%, and 0.874, respectively, with the best cut-off value of 180.6 for females.

Conclusions

Using transcutaneous ultrasound, the IP index may be a valuable diagnostic parameter for MML in cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–61.

    Article  PubMed  Google Scholar 

  2. Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008;28:110–22.

    Article  CAS  PubMed  Google Scholar 

  3. Cardenas A, Gines P. Management of patients with cirrhosis awaiting liver transplantation. Gut. 2011;60:412–21.

    Article  PubMed  Google Scholar 

  4. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–73.

    Article  PubMed  Google Scholar 

  5. Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis. 2012;16:95–131.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.

    Article  CAS  PubMed  Google Scholar 

  7. Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transplant. 2012;18:1209–16.

    Article  Google Scholar 

  8. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 2013;47:861–70.

    Article  PubMed  Google Scholar 

  10. Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.

    Article  CAS  PubMed  Google Scholar 

  11. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115–22.

    Article  CAS  PubMed  Google Scholar 

  12. Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60:1151–7.

    Article  PubMed  Google Scholar 

  13. Sergi G, Trevisan C, Veronese N, et al. Imaging of sarcopenia. Eur J Radiol. 2016;85:1519–24.

    Article  PubMed  Google Scholar 

  14. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 1997;113:1609–16.

    Article  CAS  PubMed  Google Scholar 

  16. Colli A, Fraquelli M, Andreoletti M, et al. Severe liver fibrosis or cirrhosis: accuracy of US for detection—analysis of 300 cases. Radiology. 2003;227:89–94.

    Article  PubMed  Google Scholar 

  17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.

    Article  CAS  PubMed  Google Scholar 

  18. Nishikawa H, Shiraki M, Hiramatsu A, et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016;46:951–63.

    Article  PubMed  Google Scholar 

  19. Kondo T, Maruyama H, Sekimoto T, et al. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis. Scand J Gastroenterol. 2016;51:236–44.

    Article  PubMed  Google Scholar 

  20. Masuda T, Shirabe K, Ikegami T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transplant. 2014;20:401–7.

    Article  Google Scholar 

  21. Hamaguchi Y, Kaido T, Okumura S, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transplant. 2014;20:1413–9.

    Article  Google Scholar 

  22. Hanai T, Shiraki M, Nishimura K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193–9.

    Article  PubMed  Google Scholar 

  23. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.

    Article  PubMed  Google Scholar 

  24. Cardinot TM, Aragao AH, Babinski MA, et al. Rare variation in course and affluence of internal iliac vein due to its anatomical and surgical significance. Surg Radiol Anat. 2006;28:422–5.

    Article  CAS  PubMed  Google Scholar 

  25. Kose MF, Turan T, Karasu Y, et al. Anomalies of major retroperitoneal vascular structure. Int J Gynecol Cancer. 2011;21:1312–9.

    PubMed  Google Scholar 

  26. Arts IM, Pillen S, Overeem S, et al. Rise and fall of skeletal muscle size over the entire life span. J Am Geriatr Soc. 2007;55:1150–2.

    Article  PubMed  Google Scholar 

  27. Arts IM, Pillen S, Schelhaas HJ, et al. Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve. 2010;41:32–41.

    Article  PubMed  Google Scholar 

  28. Fukumoto Y, Ikezoe T, Yamada Y, et al. Age-related ultrasound changes in muscle quantity and quality in women. Ultrasound Med Biol. 2015;41:3013–7.

    Article  PubMed  Google Scholar 

  29. Tandon P, Low G, Mourtzakis M, et al. A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:1473–80.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hitoshi Maruyama.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest and have not received any financial support for this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobayashi, K., Maruyama, H., Kiyono, S. et al. Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis. J Gastroenterol 53, 652–659 (2018). https://doi.org/10.1007/s00535-017-1378-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-017-1378-2

Keywords

Navigation